These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 2573212)
1. Multiple action compounds in angina pectoris. Kelly DT; Freedman SB Z Kardiol; 1989; 78 Suppl 3():16-20. PubMed ID: 2573212 [TBL] [Abstract][Full Text] [Related]
2. Carvedilol versus verapamil in chronic stable angina: a multicentre trial. Hauf-Zachariou U; Blackwood RA; Gunawardena KA; O'Donnell JG; Garnham S; Pfarr E Eur J Clin Pharmacol; 1997; 52(2):95-100. PubMed ID: 9174677 [TBL] [Abstract][Full Text] [Related]
3. Effects of carvedilol in patients with impaired left ventricular function due to ischaemic heart disease. Lahiri A; Rodrigues EA; DasGupta P; Jain D; van der Does R; Raftery EB Z Kardiol; 1989; 78 Suppl 3():21-7. PubMed ID: 2573213 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of carvedilol in comparison with nifedipine sustained-release in chronic stable angina. van der Does R; Eberhardt R; Derr I; Ehmer B J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S122-7. PubMed ID: 1378139 [TBL] [Abstract][Full Text] [Related]
5. Antianginal efficacy of carvedilol, a new beta-blocker with vasodilating action. Jamal SM; Freedman SB; Thomson A; Carter G; Harris PJ; Kelly DT J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S141-6. PubMed ID: 2454361 [TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic stable angina with carvedilol: a multiple-action neurohormonal antagonist. A review of controlled clinical trials. González Maqueda I J Int Med Res; 1998; 26(3):107-19. PubMed ID: 9718465 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of a new vasodilating beta-blocking agent, carvedilol, in exertional angina using holter monitoring. Kishida H; Saito T; Fukuma N; Hata N; Suzuki T; Ohtsu F Jpn Heart J; 1990 Jul; 31(4):449-60. PubMed ID: 1977939 [TBL] [Abstract][Full Text] [Related]
8. Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. McTavish D; Campoli-Richards D; Sorkin EM Drugs; 1993 Feb; 45(2):232-58. PubMed ID: 7681374 [TBL] [Abstract][Full Text] [Related]
9. Anti-Anginal and Metabolic Effects of Carvedilol and Atenolol in Patients with Stable Angina Pectoris: A Prospective, Randomized, Parallel, Open-Label Study. Oh PC; Kang WC; Moon J; Park YM; Kim S; Kim MG; Lee K; Ahn T; Shin EK Am J Cardiovasc Drugs; 2016 Jun; 16(3):221-8. PubMed ID: 27021556 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of carvedilol in exercise-induced myocardial ischemia. Kaski JC; Rodriguez-Plaza L; Brown J; Maseri A J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S137-40. PubMed ID: 2454360 [TBL] [Abstract][Full Text] [Related]
18. [Efficacy and tolerability of felodipine and nifedipine in stable angina refractory to beta-blocker therapy]. Mazzotta G; Falcidieno M; Ravera E; Vecchio C G Ital Cardiol; 1996 Apr; 26(4):407-17. PubMed ID: 8707025 [TBL] [Abstract][Full Text] [Related]
19. [Effects of nipradilol on the patients of angina pectoris: results from the study of the exercise electrocardiography using HR-ST loop method]. Maehara K; Morita M; Fukushima T; Sakurai K; Koseki Y; Takishima T Kokyu To Junkan; 1993 Mar; 41(3):255-60. PubMed ID: 8097055 [TBL] [Abstract][Full Text] [Related]
20. Beta-blockers in heart failure. Do they improve the quality as well as the quantity of life? Fowler MB Eur Heart J; 1998 Dec; 19 Suppl P():P17-25. PubMed ID: 9886708 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]